Compare · ESYN vs MEDS

ESYN vs MEDS

Side-by-side comparison of EnerSyn Global Inc. (ESYN) and DataMeds AI Inc. (MEDS): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both ESYN and MEDS operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
  • ESYN is the larger of the two at $48.5M, about 8.5x MEDS ($5.7M).
  • MEDS has hit the wire 7 times in the past 4 weeks while ESYN has been quiet.
  • MEDS has more recent analyst coverage (1 ratings vs 0 for ESYN).
MetricESYNMEDS
Company
EnerSyn Global Inc.
DataMeds AI Inc.
Price
-
-
Market cap
$48.5M
$5.7M
1M return
-
-
1Y return
-
-
Industry
Other Pharmaceuticals
Other Pharmaceuticals
Exchange
NASDAQ
NASDAQ
IPO
2022
News (4w)
0
7
Recent ratings
0
1
ESYN

EnerSyn Global Inc.

Previously known as HWH International Inc., the Company operates as a purpose-driven lifestyle company encompassing differentiated offerings to develop new pathways to help people in their pursuit of Health, Wealth and Happiness. The Company's management team has begun to evaluate a range of additional growth and investment opportunities that it believes can build long-term shareholder value and drive strong, sustainable growth. The Company intends to pursue such opportunities selectively and prudently, in a manner management deems beneficial to, and aligned with the long-term interests of its stockholders. The Company believes that energy represents a new addition to the Company that may provide favorable opportunities.

MEDS

DataMeds AI Inc.

DataMEDS AI, Inc. (NASDAQ:MEDS), formerly Wellgistics Health, Inc., is a healthcare company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units through its health information technology platforms to deliver a better experience for consumers and providers. Headquartered in Tampa, Fla., DataMEDS incorporates its EinsteinRx artificial intelligence platform and PharmacyChain blockchain-enabled smart contracts platform into the Health Lives Here mobile application from Tollo Health, LLC, and its pharmacy-related Corexa Health subsidiary provides pharmacy dispensing and pharmacy-related services, including distribution of products developed by Tollo Health. DataMEDS also owns Helomics Corporation, a Pittsburgh, PA -based commercial clinical molecular diagnostics laboratory focused on the ChemoFx Assay chemotherapy selection diagnostics test that aims to help oncologists make chemotherapy treatment decisions.